Company profile STIM

Neuronetics Inc
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the f...irst company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Show More
Quarter analysis & expected interestLast update: February 09 2024 18:20:24.

After 39 days of this quarter the interest is at 149.0. Based on that we can calculate that during remaining 52 days it will total up to 348.0.
Neuronetics expected interest is significantly higher compared to previous quarter (+75.8%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019404
378
-6.4% QoQ
267
-29.4% QoQ
348
30.3% QoQ
2020 392
-3.0% YoY 12.6% QoQ
416
10.1% YoY 6.1% QoQ
242
-9.4% YoY -41.8% QoQ
323
-7.2% YoY 33.5% QoQ
2021 447
14.0% YoY 38.4% QoQ
328
-21.2% YoY -26.6% QoQ
437
80.6% YoY 33.2% QoQ
212
-34.4% YoY -51.5% QoQ
2022 273
-38.9% YoY 28.8% QoQ
423
29.0% YoY 54.9% QoQ
313
-28.4% YoY -26.0% QoQ
93
-56.1% YoY -70.3% QoQ
2023 296
8.4% YoY 218.3% QoQ
271
-35.9% YoY -8.4% QoQ
123
-60.7% YoY -54.6% QoQ
198
112.9% YoY 61.0% QoQ
2024 149
-49.7% YoY -24.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Neuronetics search interestLast update: February 09 2024 18:20:23.
Correlation coefficient between keyword and revenue is -0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:20:25.

The average 5 years interest of Neuronetics was 24.26 per week.
The last year interest of Neuronetics compared to the last 5 years has changed by -25.8%.
The interest for Neuronetics is significantly decreasing.
The last year interest is quite lower compared to 5 years ago. It has decreased by -37.52%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NeuroStar Advanced Therapy System to provide analysis

Correlation between past revenue and NeuroStar Advanced Therapy System search interest

There is not enough data for NeuroStar Advanced Therapy System to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NeuroStar Advanced Therapy System to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:20:31.

After 39 days of this quarter the interest is at 325.0. Based on that we can calculate that during remaining 52 days it will total up to 758.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019460
701
52.4% QoQ
692
-1.3% QoQ
670
-3.2% QoQ
2020 652
41.7% YoY -2.7% QoQ
513
-26.8% YoY -21.3% QoQ
650
-6.1% YoY 26.7% QoQ
615
-8.2% YoY -5.4% QoQ
2021 592
-9.2% YoY -3.7% QoQ
665
29.6% YoY 12.3% QoQ
564
-13.2% YoY -15.2% QoQ
647
5.2% YoY 14.7% QoQ
2022 888
50.0% YoY 37.2% QoQ
857
28.9% YoY -3.5% QoQ
778
37.9% YoY -9.2% QoQ
771
19.2% YoY -0.9% QoQ
2023 760
-14.4% YoY -1.4% QoQ
822
-4.1% YoY 8.2% QoQ
758
-2.6% YoY -7.8% QoQ
790
2.5% YoY 4.2% QoQ
2024 325
-57.2% YoY -58.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and transcranial magnetic stimulation search interestLast update: February 09 2024 18:20:30.
Correlation coefficient between keyword and revenue is 0.63
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:20:31.

The average 5 years interest of transcranial magnetic stimulation was 54.29 per week.
The last year interest of transcranial magnetic stimulation compared to the last 5 years has changed by 11.25%.
The interest for transcranial magnetic stimulation is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 13.07%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Neuronetics headquarters to provide analysis

Correlation between past revenue and Neuronetics headquarters search interest

There is not enough data for Neuronetics headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Neuronetics headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:20:36.

After 39 days of this quarter the interest is at 66.0. Based on that we can calculate that during remaining 52 days it will total up to 154.0.
Neuronetics stock expected interest is significantly higher compared to previous quarter (+79.1%) and same quarter last year (+81.2%).

YearQ1Q2Q3Q4
201972
34
-52.8% QoQ
80
135.3% QoQ
61
-23.8% QoQ
2020 43
-40.3% YoY -29.5% QoQ
161
373.5% YoY 274.4% QoQ
108
35.0% YoY -32.9% QoQ
127
108.2% YoY 17.6% QoQ
2021 237
451.2% YoY 86.6% QoQ
74
-54.0% YoY -68.8% QoQ
60
-44.4% YoY -18.9% QoQ
69
-45.7% YoY 15.0% QoQ
2022 52
-78.1% YoY -24.6% QoQ
23
-68.9% YoY -55.8% QoQ
98
63.3% YoY 326.1% QoQ
52
-24.6% YoY -46.9% QoQ
2023 85
63.5% YoY 63.5% QoQ
55
139.1% YoY -35.3% QoQ
56
-42.9% YoY 1.8% QoQ
86
65.4% YoY 53.6% QoQ
2024 66
-22.4% YoY -23.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Neuronetics stock search interestLast update: February 09 2024 18:20:35.
Correlation coefficient between keyword and revenue is -0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:20:37.

The average 5 years interest of Neuronetics stock was 6.51 per week.
The last year interest of Neuronetics stock compared to the last 5 years has changed by -17.05%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 13.68%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NeuroStar system to provide analysis

Correlation between past revenue and NeuroStar system search interest

There is not enough data for NeuroStar system to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NeuroStar system to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:20:44.

After 39 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 52 days it will total up to 79.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201949
305
522.4% QoQ
115
-62.3% QoQ
101
-12.2% QoQ
2020 39
-20.4% YoY -61.4% QoQ
143
-53.1% YoY 266.7% QoQ
139
20.9% YoY -2.8% QoQ
89
-11.9% YoY -36.0% QoQ
2021 78
100.0% YoY -12.4% QoQ
107
-25.2% YoY 37.2% QoQ
51
-63.3% YoY -52.3% QoQ
33
-62.9% YoY -35.3% QoQ
2022 118
51.3% YoY 257.6% QoQ
30
-72.0% YoY -74.6% QoQ
49
-3.9% YoY 63.3% QoQ
23
-30.3% YoY -53.1% QoQ
2023 77
-34.7% YoY 234.8% QoQ
119
296.7% YoY 54.5% QoQ
84
71.4% YoY -29.4% QoQ
65
182.6% YoY -22.6% QoQ
2024 34
-55.8% YoY -47.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NeuroStar treatment search interestLast update: February 09 2024 18:20:44.
Correlation coefficient between keyword and revenue is 0.01
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:20:47.

The average 5 years interest of NeuroStar treatment was 7.08 per week.
The last year interest of NeuroStar treatment compared to the last 5 years has changed by -2.26%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -39.03%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:20:55.

After 39 days of this quarter the interest is at 112.0. Based on that we can calculate that during remaining 52 days it will total up to 261.0.
major depressive disorder treatment expected interest is significantly lower compared to previous quarter (-63.3%) and same quarter last year (-49.2%).

YearQ1Q2Q3Q4
2019257
265
3.1% QoQ
216
-18.5% QoQ
319
47.7% QoQ
2020 284
10.5% YoY -11.0% QoQ
322
21.5% YoY 13.4% QoQ
186
-13.9% YoY -42.2% QoQ
430
34.8% YoY 131.2% QoQ
2021 367
29.2% YoY -14.7% QoQ
327
1.6% YoY -10.9% QoQ
253
36.0% YoY -22.6% QoQ
389
-9.5% YoY 53.8% QoQ
2022 507
38.1% YoY 30.3% QoQ
591
80.7% YoY 16.6% QoQ
307
21.3% YoY -48.1% QoQ
612
57.3% YoY 99.3% QoQ
2023 514
1.4% YoY -16.0% QoQ
604
2.2% YoY 17.5% QoQ
382
24.4% YoY -36.8% QoQ
712
16.3% YoY 86.4% QoQ
2024 112
-78.2% YoY -84.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and major depressive disorder treatment search interestLast update: February 09 2024 18:20:54.
Correlation coefficient between keyword and revenue is 0.49
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:20:57.

The average 5 years interest of major depressive disorder treatment was 30.48 per week.
The last year interest of major depressive disorder treatment compared to the last 5 years has changed by 35.14%.
The interest for major depressive disorder treatment is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 89.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for non-invasive depression treatment to provide analysis

Correlation between past revenue and non-invasive depression treatment search interest

There is not enough data for non-invasive depression treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for non-invasive depression treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for non-systemic depression treatment to provide analysis

Correlation between past revenue and non-systemic depression treatment search interest

There is not enough data for non-systemic depression treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for non-systemic depression treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for STIM
Earnings date: 2024-03-05 After close
Company name: Neuronetics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T12:32:00Z

GlobeNewswire
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

2026-05-05T11:50:00Z

GlobeNewswire
Neuronetics Reports First Quarter 2026 Financial and Operating Results

2026-04-29T20:30:00Z

GlobeNewswire
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-04-21T12:30:00Z

GlobeNewswire
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

2026-04-13T12:32:00Z

GlobeNewswire
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

2026-04-07T11:00:00Z

GlobeNewswire
Neuronetics Comments on Letter from Pointillist Family Office

2026-04-06T20:30:00Z

GlobeNewswire
Neuronetics Announces Chief Financial Officer Transition

2026-04-06T16:05:00-04:00

PR Newswire
Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business

2026-03-19T18:53:33Z

Analyst Upgrades
Canaccord Genuity Maintains Buy on Neuronetics, Lowers Price Target to $3

2026-03-03T13:30:00Z

GlobeNewswire
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

2026-02-24T12:05:00Z

BusinessWire
Diality Appoints Peter Donato as Chief Financial Officer

2026-02-10T21:34:49Z

GlobeNewswire
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

2025-11-20T13:30:00Z

GlobeNewswire
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

2025-11-12T15:33:00Z

GlobeNewswire
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

2025-11-04T12:05:00Z

GlobeNewswire
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan